(Q43923516)

28 November 2017

title

Anti-oxidant ebselen causes the resolution of experimentally induced hepatic fibrosis in rats (English)

1 reference

28 November 2017

Wasser S

1

1 reference

28 November 2017

Lim GY

series ordinal

2

1 reference

28 November 2017

Ong CN

series ordinal

3

1 reference

28 November 2017

Tan CE

series ordinal

4

1 reference

28 November 2017

publication date

1 November 2001

1 reference

Journal of Gastroenterology and Hepatology

28 November 2017

published in

1 reference

28 November 2017

volume

16

1 reference

28 November 2017

issue

11

1 reference

28 November 2017

page(s)

1244-1253

1 reference

Liver fibrosis and extracellular matrix

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

In vitro and in vivo association of transforming growth factor-beta 1 with hepatic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Cellular distribution of transforming growth factor-beta 1 and procollagen types I, III, and IV transcripts in carbon tetrachloride-induced rat liver fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Connective tissue metabolism and hepatic fibrosis: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Transforming growth factor beta in tissue fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Cell-matrix interactions in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Matrix degradation in the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Proteolytic remodeling of extracellular matrix

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

CYP2E1-mediated oxidative stress induces collagen type I expression in rat hepatic stellate cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Mechanisms of liver cell injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Cytochrome P450 2E1 is the primary enzyme responsible for low-dose carbon tetrachloride metabolism in human liver microsomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Liver fibrogenesis and the role of hepatic stellate cells: new insights and prospects for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Ebselen: prospective therapy for cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Ebselen: a glutathione peroxidase mimic

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Protective effect of ebselen against hydrogen peroxide-induced cytotoxicity and DNA damage in HepG2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Inhibition of ebselen on aflatoxin B(1)-induced hepatocarcinogenesis in Fischer 344 rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

A novel biologically active seleno-organic compound--VI. Protection by ebselen (PZ 51) against galactosamine/endotoxin-induced hepatitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Induction of early-immediate genes by tumer necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Induction of cyclooxygenase 1 and 2 in the rat stomach during endotoxemia: role in resistance to damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Antibodies against transforming growth factor-beta 1 suppress intimal hyperplasia in a rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Experimental models of hepatic fibrosis: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Hepatic lipocytes: the principal collagen-producing cells of normal rat liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Extracellular matrix gene expression increases preferentially in rat lipocytes and sinusoidal endothelial cells during hepatic fibrosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Cellular sources of collagen and regulation of collagen production in liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Alcoholic liver disease: new insights in pathogenesis lead to new treatments

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Oxidants, antioxidants, and the degenerative diseases of aging

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

A novel biologically active seleno-organic compound—1

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1440-1746.2001.02621.X

10.1046/J.1440-1746.2001.02621.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference